KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.265 $5.95 Friday, 26th Apr 2024 WINT stock ended at $5.23. This is 3.15% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.89% from a day low at $5.06 to a day high of $5.51.
90 days $0.265 $5.95
52 weeks $0.265 $5.95

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
Apr 11, 2016 $2.55 $3.34 $2.50 $3.03 923 818
Apr 08, 2016 $2.27 $2.50 $2.23 $2.50 256 501
Apr 07, 2016 $1.90 $2.23 $1.83 $2.23 134 995
Apr 06, 2016 $1.74 $1.90 $1.73 $1.90 47 911
Apr 05, 2016 $1.70 $1.76 $1.68 $1.72 9 084
Apr 04, 2016 $1.63 $1.74 $1.63 $1.70 17 827
Apr 01, 2016 $1.65 $1.70 $1.65 $1.65 6 560
Mar 31, 2016 $1.59 $1.68 $1.59 $1.67 16 311
Mar 30, 2016 $1.60 $1.69 $1.55 $1.56 18 875
Mar 29, 2016 $1.54 $1.74 $1.43 $1.61 170 200
Mar 28, 2016 $1.61 $1.61 $1.51 $1.59 61 800
Mar 24, 2016 $1.79 $1.85 $1.57 $1.60 282 600
Mar 23, 2016 $1.69 $1.90 $1.68 $1.74 119 300
Mar 22, 2016 $1.68 $1.70 $1.60 $1.64 53 400
Mar 21, 2016 $1.61 $1.70 $1.57 $1.66 41 300
Mar 18, 2016 $1.55 $1.68 $1.55 $1.65 57 700
Mar 17, 2016 $1.58 $1.64 $1.53 $1.58 35 700
Mar 16, 2016 $1.69 $1.69 $1.60 $1.63 16 900
Mar 15, 2016 $1.72 $1.72 $1.55 $1.65 30 000
Mar 14, 2016 $1.65 $1.76 $1.61 $1.75 38 600
Mar 11, 2016 $1.70 $1.78 $1.59 $1.60 147 900
Mar 10, 2016 $1.75 $1.80 $1.70 $1.71 25 200
Mar 09, 2016 $1.92 $1.92 $1.68 $1.79 64 700
Mar 08, 2016 $2.04 $2.06 $1.85 $1.90 156 700
Mar 07, 2016 $1.99 $2.10 $1.99 $2.05 24 500
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT